Improved preparation and identification of aristolochic acid-DNA adducts by solid-phase extraction with liquid chromatography-tandem mass spectrometry

Journal of Environmental Sciences

Volumn 21, Issue 12, 2009, Pages 1769-1776

  GAO, Haiyan ^a,b   GUO, Fangqiu ^b   FENG, Feng ^a   YIN, Junfa ^a   SONG, Maoyong ^a   WANG, Hailin ^a  

^a RESEARCH CENTER FOR ECO ENVIRONMENTAL SCIENCES   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

aristolochic acid; DNA adducts; quadrupole; solid phase extraction; time of flight tandem mass spectrometry

Indexed keywords

ASCORBIC ACID; DNA; ELECTROSPRAY IONIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETRY; MIXTURES; PHASE SEPARATION; PURIFICATION;

ARISTOLOCHIC ACID; DNA ADDUCTS; QUADRUPOLES; SOLID-PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

EXTRACTION;

DNA; EXTRACTION METHOD; IONIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

EID: 72149119997     PISSN: 10010742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1001-0742(08)62486-9     Document Type: Article

References (32)

1. Arlt V.M., Ferluga D., Stiborova M., Pfohl-Leszkowicz A., Vukelic M., Ceovic S., et al. Is aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer?. International Journal of Cancer 101 5 (2002) 500-502
2. Arlt V.M., Pfohl-Leszkowicz A., Cosyns J.P., and Schmeiser H.H. Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy. Mutation Research 494 1-2 (2001) 143-150
3. 32P-postlabelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy. Carcinogenesis 18 5 (1997) 1063-1067
4. Chan W., Zheng Y., and Cai Z.W. Liquid chromatography tandem mass spectrometry analysis of the DNA adducts of aristolochic acids. Journal of the American Society for Mass Spectrometry 18 4 (2007) 642-650
5. Chan W., Lee K.C., Liu N., and Cai Z.W. A sensitivity enhanced high-performance liquid chromatography fluorescence method for the detection of nephrotoxic and carcinogenic aristolochic acid in herbal medicines. Journal of Chromatography A 1164 1-2 (2007) 113-119
6. Chan W., and Cai Z.W. Aristolochic acid induced changes in the metabolic profile of rat urine. Journal of Pharmaceutical and Biomedical Analysis 46 4 (2008) 757-762
7. Chan W., Yue H., Poon W.T., Chan Y.W., Schmitz O.J., Kwong D.W., et al. Quantification of aristolochic acid-derived DNA adducts in rat kidney and liver by using liquid chromatography-electrospray ionization mass spectrometry. Mutation Research 646 1-2 (2008) 17-24
8. Debelle F.D., Vanherweghem J.L., and Nortier J.L. Aristolochic acid nephropathy: A worldwide problem. Kidney International 74 2 (2008) 158-169
9. Domijan A.M., and Sarić M. Mycotoxic and aristolochic acid theories of the development of endemic nephropathy. Arh Hig Rada Toksikol 59 1 (2008) 59-65
10. 32P-postlabelling/polyacrylamide gel electrophoresis analysis. Drug Metabolism and Disposition 34 7 (2006) 1122-1127
11. Feng F., Yin J.F., Song M.Y., and Wang H.L. Preparation, identi-fication and analysis of stereoisomeric anti-benzo[a]pyrene diol epoxide-deoxyguanosine adducts using phenyl liquid chromatography with diode array, fluorescence and tandem mass spectrometry detection. Journal of Chromatography A 1183 1-2 (2008) 119-128
12. Flarakos J., Xiong W.N., Glick J., and Vouros P. A deoxynucleotide derivatization methodology for improving LC-ESI-MS detection. Analytical Chemistry 77 (2005) 2373-2380
13. Gaskell M., Kaur B., Farmer P.B., and Singh R. Detection of phosphodiester adducts formed by the reaction of benzo[a]pyrene diol epoxide with 2′-deoxynucleotides using collision-induced dissociation electrospray ionization tandem mass spectrometry. Nucleic Acids Research 35 15 (2007) 5014-5027
14. Grollman A.P., Shibutani S., Moriya M., Miller F., Wu L., Moll U., et al. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proceedings of the National Academy of Sciences of the United States of American 104 29 (2007) 12129-12134
15. Ji W.X., Liu M.X., Yang C.D., and Chen Y.P. Synthesis and mass spectrometric analysis of aristolochic acid-deoxyguanosine adducts. Acta Pharmaceutica Sinica 43 3 (2008) 295-298
16. Kohara A., Suzuki T., Honma M., Ohwada T., and Hayashi M. Mutagenicity of aristolochic acid in the lambda/lacZ transgenic mouse (MutaMouse). Mutation Research 515 1-2 (2002) 63-72
17. Kupchan M.S., and Doskotch R.W. Tumor inhibitors I, aristolochic acid, the active principle of Aristolochia indica. Journal of Medicinal and Pharmaceutical Chemistry 5 3 (1962) 657-659
18. Mei N., Arlt V.M., Phillips D.H., Heflich R.H., and Chen T. DNA adduct formation and mutation induction by aristolochic acid in rat kidney and liver. Mutation Research 602 1-2 (2006) 83-91
19. Mengs U. Acute toxicity of aristolochic acid in rodents. Archives of Toxicology 59 5 (1987) 328-331
20. Mengs U. Tumor induction in mice following exposure to aristolochic acid. Archives of Toxicology 61 6 (1988) 504-505
21. Mengs U., and Stotzem C.D. Renal toxicity of aristolochic acid in rats as an example of nephrotoxicity testing in routine toxicology. Archives of Toxicology 67 5 (1993) 307-311
22. Mix D.B., Guinaudeau H., and Sharmma M. The aristolochic acids and aristolactams. Journal of Natural Products 45 6 (1982) 657-666
23. Pfau W., Schmeiser H.H., and Wiessler M. Aristolochic acid binds covalently to exocyclic amino group of purine nucleotides in DNA. Carcinogenesis 11 2 (1990) 313-319
24. Rucker V.G., and Chung B.S. Aristolochic acids from Aristolochia manshuriensis (author's transl). Planta Medica 27 1 (1975) 68-71
25. Schmeiser H.H., Bieter C.A., Wiessler M., Strihou C.Y., and Cosyns J.P. Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Research 56 9 (1996) 2025-2028
26. Schmeiser H.H., Pool B.L., and Wiessler M. Identification and mutagenicity of metabolites of aristolochic acid formed by rat liver. Carcinogenesis 7 1 (1986) 59-63
27. 32P-postlabelling: evidence for reductive activation by peroxidases. Carcino-genesis 18 5 (1997) 1055-1062
28. Shibutani S., Dong H., Suzuki N., Ueda S., Miller F., and Grollman A.P. Selective toxicity of aristolochic acids I and II. Drug Metabolism and Disposition 35 7 (2007) 1217-1222
29. Singh R., and Farmer P.B. Liquid chromatography-electrospray ionization-mass spectrometry: the future of DNA adduct detection. Carcinogenesis 27 2 (2006) 178-196
30. Stefanovic V., Toncheva D., Atanasova S., and Polenakovic M. Etiology of Balkan endemic nephropathy and associated urothelial cancer. American Journal of Nephrology 26 1 (2006) 1-11
31. Stiborova M., Frei E., Arlt V.M., and Schmeiser H.H. Metabolic activation of carcinogenic aristolochic acid, a risk factor for Balkan endemic nephropathy. Mutation Research 658 1-2 (2008) 55-67
32. Vanherweghem J.L., Depierreux M., Tielemans C., Abramowicz D., Dratwa M., Jadoul M., et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. The Lancet 341 8842 (1993) 387-391